Fetal bovine serum

Ended Purchase Order Awarded Last action

Contract number
75N91023P00806
Awardee
Awarding agency
Obligated
$19,962

Award facts

Contract value 100% obligated
$19,961.98 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Encinitas, CA 92024, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,961.98 purchase order to Cell Culture Collective, Inc. for fetal bovine serum. Cell Culture Collective, Inc. will deliver the requested serum to support biomedical research efforts under this firm fixed price contract. Performance will take place in Encinitas, California over a one-month period concluding in late September 2023. No set aside designation or subcontractors were identified. This contract advances the National Cancer Institute's mission to lead the nation's cancer research efforts through supporting the use of fetal bovine serum in laboratory experiments seeking to understand and treat cancer.

Quick answers

Who was awarded contract 75N91023P00806?

75N91023P00806 was awarded to Cell Culture Collective, Inc. by National Cancer Institute (National Institutes of Health) on August 28, 2023.

How much is contract 75N91023P00806 worth?

The government has obligated $19,962 on 75N91023P00806.

Was contract 75N91023P00806 competed?

The extent of competition for 75N91023P00806 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award